{
    "clinical_study": {
        "@rank": "82249", 
        "acronym": "ATHENA", 
        "arm_group": [
            {
                "arm_group_label": "Standart", 
                "arm_group_type": "Active Comparator"
            }, 
            {
                "arm_group_label": "Tacrolimus", 
                "arm_group_type": "Experimental"
            }, 
            {
                "arm_group_label": "Cyclosporine", 
                "arm_group_type": "Experimental"
            }
        ], 
        "brief_summary": {
            "textblock": "This study is designed to evaluate the renal function comparing Certican based\n      immunosuppressive regimens with two different CNIs (Tacrolimus or Cyclosporin A) versus a\n      standard treatment with Mycophenolic Acid and Tacrolimus in de novo renal transplant\n      recipients."
        }, 
        "brief_title": "12 Month Athena Study: Everolimus vs. Standard Regimen in de Novo Kidney Transplant Patients", 
        "completion_date": {
            "#text": "October 2016", 
            "@type": "Anticipated"
        }, 
        "condition": "Kidney Transplantation, Renal Transplantation", 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Patient who has received a primary or secondary kidney transplant\n\n          -  Patients who are willing and from whom written informed consent has been obtained\n\n          -  kidney allograft with a cold ischemia time (CIT) < 30 hours\n\n          -  negative pregnancy test prior to study enrollment\n\n          -  Other protocol-defined inclusion/exclusion criteria may apply\n\n        Exclusion Criteria:\n\n          -  Other protocol-defined inclusion/exclusion criteria may apply\n\n          -  Multi-organ recipients\n\n          -  former Graft loss due to immunological reasons\n\n          -  Patients receiving a kidney from a non-heart beating donor\n\n          -  A-B-0 incompatible transplants\n\n          -  a current Panel Reactive Antibody (PRA) level of > 20%\n\n          -  existing antibodies against the HLA-type of the receiving transplant\n\n          -  a known hypersensitivity/contraindication to any of the immunosuppressants\n\n          -  Use of other investigational drugs\n\n          -  Patients with thrombocytopenia (platelets < 100,000/mm\u00b3), with an absolute neutrophil\n             count of < 2,000/mm\u00b3 or leucopenia (leucocytes < 3,000/mm\u00b3), or hemoglobin < 8 g/dL\n\n          -  significant mental illness\n\n          -  history of malignancy during the last five years\n\n          -  HIV positive\n\n          -  uncontrolled hypercholesterolemia or hypertriglyceridemia\n\n          -  drug or alcohol abuse\n\n          -  pregnant or breast feeding women"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "612", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "April 18, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01843348", 
            "org_study_id": "CRAD001ADE44", 
            "secondary_id": "2011-005238-21"
        }, 
        "intervention": [
            {
                "arm_group_label": [
                    "Tacrolimus", 
                    "Cyclosporine"
                ], 
                "intervention_name": "RAD001", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": [
                    "Standart", 
                    "Tacrolimus"
                ], 
                "description": "Tacrolimus: one capsule containing 0.5 mg, 1 mg or 5 mg", 
                "intervention_name": "Tacrolimus", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Cyclosporine", 
                "description": "one capsule containing 10 mg, 25 mg, 50 mg or 100 mg", 
                "intervention_name": "Cyclosporin A", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Standart", 
                "description": "one tablet containing 180 mg or 360 mg (EC-MPS) or or 500 mg (MMF), one capsule containing 250 mg (MMF)", 
                "intervention_name": "Enteric Coated Mycophenolate Sodium (EC-MPS) or Mycophenolate Mofetil (MMF)", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": [
                    "Standart", 
                    "Tacrolimus", 
                    "Cyclosporine"
                ], 
                "description": "A minimum dose of 5 mg prednisolon or equivalent", 
                "intervention_name": "Corticosteroids", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Cyclosporins", 
                "Cyclosporine", 
                "Mycophenolic Acid", 
                "Mycophenolate mofetil", 
                "Everolimus", 
                "Tacrolimus"
            ]
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "March 23, 2014", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Bordeaux Cedex", 
                        "country": "France", 
                        "zip": "33076"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Brest", 
                        "country": "France", 
                        "zip": "29200"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Creteil", 
                        "country": "France", 
                        "zip": "94010"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Dijon", 
                        "country": "France", 
                        "zip": "21079"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Lille Cedex", 
                        "country": "France", 
                        "zip": "59037"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Lyon", 
                        "country": "France", 
                        "zip": "69437"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Nantes", 
                        "country": "France", 
                        "zip": "44035"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Paris", 
                        "country": "France", 
                        "zip": "75970"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Poitiers", 
                        "country": "France", 
                        "zip": "86000"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "St Priest en Jarez Cedex", 
                        "country": "France", 
                        "zip": "42277"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Strasbourg", 
                        "country": "France", 
                        "zip": "67091"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Suresnes", 
                        "country": "France", 
                        "zip": "92150"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Withdrawn"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Toulouse Cedex 4", 
                        "country": "France", 
                        "zip": "31054"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Aachen", 
                        "country": "Germany", 
                        "zip": "52074"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Berlin", 
                        "country": "Germany", 
                        "zip": "13353"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Bochum", 
                        "country": "Germany", 
                        "zip": "44892"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Dresden", 
                        "country": "Germany", 
                        "zip": "01307"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Erlangen", 
                        "country": "Germany", 
                        "zip": "91052"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Essen", 
                        "country": "Germany", 
                        "zip": "45147"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Frankfurt", 
                        "country": "Germany", 
                        "zip": "60590"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Freiburg", 
                        "country": "Germany", 
                        "zip": "79106"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Hamburg", 
                        "country": "Germany", 
                        "zip": "20246"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Hannover", 
                        "country": "Germany", 
                        "zip": "30625"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Heidelberg", 
                        "country": "Germany", 
                        "zip": "69120"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Kiel", 
                        "country": "Germany", 
                        "zip": "24105"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Mainz", 
                        "country": "Germany", 
                        "zip": "55131"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Muenster", 
                        "country": "Germany", 
                        "zip": "48149"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "T\u00fcbingen", 
                        "country": "Germany", 
                        "zip": "72076"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": [
                "France", 
                "Germany"
            ]
        }, 
        "number_of_arms": "3", 
        "official_title": "12 Month, Multi-center, Open-label, Prospective, Randomized, Parallel Group Study Investigating a Standard Regimen in de Novo Kidney Transplant Patients Versus a Certican\u00ae Based Regimen Either in Combination With Cyclosporin A or Tacrolimus", 
        "overall_contact": {
            "last_name": "Novartis Pharmaceuticals", 
            "phone": "+41613241111"
        }, 
        "overall_contact_backup": {
            "last_name": "Novartis Pharmaceuticals"
        }, 
        "overall_official": {
            "affiliation": "Novartis Pharmaceuticals", 
            "last_name": "Novartis Pharmaceuticals", 
            "role": "Study Director"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "October 2016", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "To demonstrate non-inferiority in renal function assessed by glomerular filtration rate (Nankivell formula) in at least one of the Certican\u00ae treatment regimens compared to the standard group at month 12 post-transplantation in renal transplant patients.", 
            "measure": "GFR mL/min", 
            "safety_issue": "No", 
            "time_frame": "one year"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01843348"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Novartis", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Novartis Pharmaceuticals", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "December 2012", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "March 2014"
    }
}